CompaniesMetaphore Pharmaceuticals

Metaphore Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

72

By Phase

PHASE2: 1PHASE1/PHASE2: 1

By Status

TERMINATED: 1SUSPENDED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00033956
Hover over trial bars to see details

Recent Trials

NCT00101621Lead Sponsor
Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain
PHASE2Terminated
24 participants
Started: Aug 31, 2004 · Completed: Aug 31, 2005
NCT00033956Lead Sponsor
Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2
PHASE1/PHASE2Suspended
48 participants
Started: Dec 31, 2001
Related Companies
Activbiotics
acquired